CLINICAL_TRIALS
trial_result
· 2026-03-16
Clinical Trial Update: An Evaluation of Insomnia Treatment to Reduce Cardiovascular Risk in Patients With Posttraumatic Stress Disorder [NA]
Summary
Clinical trial evaluating insomnia treatment to reduce cardiovascular risk in patients with posttraumatic stress disorder has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Duke University | Conditions: Insomnia, Posttraumatic Stress Disorder | NA | Status: COMPLETED